The Germany-based company Merck announced the acquisition of Sigma-Aldrich for approx € 13.1 billions. The deal will establish one of the leading players in the $130 billion global life science industry. The combined company will be able to serve life science customers around the world with a highly attractive set of established brands and an efficient supply chain that can support the delivery of more than 300,000 products.
“This transaction marks a milestone on our transformation journey aimed at turning our three businesses into sustainable growth platforms”, said Karl-Ludwig Kley, Chairman of Merck’s Executive Board”.